News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sabella Lauren M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
4
| Sabella Lauren M (EVP COO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 23,250 shares
@ $0
Granted 28,000 options to buy
@ $0 |
|
| 05/24/2023 |
4
| Sabella Lauren M (EVP COO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 210,000 restricted stock units
@ $0 |
|
| 05/15/2023 |
4
| Sabella Lauren M (EVP COO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 14,184 shares
@ $4.23, valued at
$60k
|
|
| 03/29/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/07/2022 |
4
| Sabella Lauren M (COO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 1,511 shares
@ $0.398, valued at
$601.4 |
|
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2020 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 3,015 shares
@ $0 |
|
| 12/04/2019 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 1,513 shares
@ $1.6002, valued at
$2.4k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2019 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 9,045 shares
@ $0
Granted 15,075 options to buy
@ $13.51, valued at
$203.7k
|
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 2,200 shares
@ $0 |
|
| 12/21/2018 |
4/A
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 3,774 shares
@ $27.84, valued at
$105.1k
|
|
| 12/06/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 1,072 shares
@ $20.2012, valued at
$21.7k
Sold 4,119 shares
@ $20.6557, valued at
$85.1k
|
|
| 11/07/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 747 shares
@ $20.28, valued at
$15.1k
|
|
| 09/12/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 2,200 shares
@ $0 |
|
| 07/02/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 5,859 shares
@ $27.8443, valued at
$163.1k
|
|
| 06/12/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 24,375 shares
@ $35, valued at
$853.1k
Exercised 24,375 options to buy
@ $16.5, valued at
$402.2k
|
|
| 05/22/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 7,288 shares
@ $23.665, valued at
$172.5k
|
|
| 03/12/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 2,085 shares
@ $25.65, valued at
$53.5k
|
|
| 02/26/2018 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 5,859 shares
@ $0 |
|
| 12/05/2017 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 1,670 shares
@ $20.5323, valued at
$34.3k
|
|
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2016 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 27,342 options to buy
@ $35.53, valued at
$971.5k
|
|
| 12/23/2015 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 7,113 shares
@ $42.0446, valued at
$299.1k
Exercised 7,113 options to buy
@ $22.06, valued at
$156.9k
|
|
| 12/21/2015 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 14,229 shares
@ $40, valued at
$569.2k
Exercised 14,229 options to buy
@ $22.06, valued at
$313.9k
|
|
| 12/03/2015 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 7,106 shares
@ $38.0638, valued at
$270.5k
|
|
| 03/06/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/03/2014 |
4
| Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 3,242 shares
@ $35.5779, valued at
$115.3k
|
|
| 03/07/2014 |
4
| Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 6,000 shares
@ $0
Granted 34,000 options to buy
@ $39.38, valued at
$1.3M
|
|
| 12/09/2013 |
4
| Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 8,797 shares
@ $31.8097, valued at
$279.8k
|
|
|
|
|